|
VeriChip Corporation Protects
More Than One Million Infants in 2007
DELRAY BEACH, FL –
February 12, 2008 – VeriChip Corporation (the “Company”) (NASDAQ:
CHIP), a provider of Radio
Frequency Identification (RFID) systems
for healthcare and patient-related needs, announced today that
Xmark’s infant protection systems, led by systems sold under the
HUGS® brand, protected more than one million
infants born in hospitals in 2007. Xmark is a
wholly owned subsidiary of VeriChip.
Daniel
A. Gunther, President and CEO
of Xmark, said, “Now more than ever, hospitals value the security
our infant protection systems bring to their labor and delivery
wards. As the leader in this industry, we are proud to protect
hospitals’ smallest and most vulnerable patients. We see sustained
growth of this business in 2008 and beyond as we continue to expand
our reach throughout North America
and other parts of the world where these systems are less common yet
no less important.”
Xmark’s infant protection systems are
designed to prevent infant abductions and inadvertent child
mismatching in hospitals. The main component of
the systems is a wearable RFID tag that is assigned to child and
mother following birth. Monitors positioned
throughout the hospital detect the integrity of the tags and
location of the child. If a newborn is removed from the ward, if the
tag is lifted from the baby’s skin or if the ankle strap is
compromised, the system immediately triggers an alarm, alerting
hospital security to the situation.
Xmark infant protection systems also
protect against mismatching events by affixing matching RFID tags to
mother and child. If the mother is given the
wrong child, the RFID tag detects the mismatch and activates an
audible alarm.
For more information on Xmark’s
products, please contact 1-866-55–XMARK or email
sales@xmark.com. Additional information can be found
online at
www.xmark.com.
About Xmark
Based in
Ottawa, Ontario,
Xmark is a wholly owned subsidiary of VeriChip Corporation.
For over 25 years, Xmark
Corporation has provided RFID solutions to identify, locate, and
protect people and assets in healthcare environments. Its
market-leading infant protection, wander prevention, personal
duress, and asset tracking applications are trusted by over 5,000
healthcare institutions worldwide to keep individuals safe.
Xmark products are installed and
serviced through an international network of authorized dealers,
backed by a dedicated technical services department at Xmark. All
aspects of Xmark’s business are certified to the ISO 9001 quality
standard.
About VeriChip
VeriChip Corporation, headquartered in
Delray Beach, Florida,
develops, markets and sells RFID systems used to identify, locate
and protect people and assets. VeriChip's goal is to become the
leading provider of RFID systems for people in the healthcare
industry. The Company recently began marketing its VeriMed(TM)
Patient Identification System, a passive RFID system for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, the implantable VeriChip(TM),
cleared for medical use in October 2004 by the United States Food
and Drug Administration.
For more information on VeriChip, please
call 1-800-970-2447, or email info@verichipcorp.com. Additional
information can be found online at
http://www.verichipcorp.com.
Statements about the
Company's future expectations, including growth of the business,
future revenues and earnings, and all other statements in this press
release other than historical facts are "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934, and as that term
is defined in the Private Litigation Reform Act of 1995. Such
forward-looking statements involve risks and uncertainties and are
subject to change at any time, and the Company's actual results
could differ materially from expected results.
Information about factors that could affect the
Company’s business is set forth in the Company’s various filings
with the Securities and Exchange Commission, including those set
forth in the Company’s 10-K filed on April 2, 2007, under the
caption “Risk Factors.” The Company undertakes no obligation to
update or release any revisions to these forward-looking statements
to reflect events or circumstances after the date of this statement
or to reflect the occurrence of unanticipated events, except as
required by law.
###
CONTACTS:
Dan Schustack
CEOcast
212-732-4300
dschustack@ceocast.com
Allison Tomek
VeriChip Corporation
(561) 805-8008
atomek@verichipcorp.com
Back
|
